• Healthcare Professionals
• Therapeutic Focus
  • Central Nervous System Disorders
    • Obstructive Sleep Apnea
    • Shift Work Sleep Disorder
    • Narcolepsy
    • Epilepsy
  • Oncology
    • Acute Promyelocytic Leukemia
    • Non-Hodgkin's Lymphoma
    • Chronic Lymphocyctic Leukemia
  • Pain
    • Breakthrough Pain in Patients with Cancer
    • Muscle Spasm Associated with Musculoskeletal Conditions
• Our Products
  • Drug Delivery Technologies
  • State Compliance
• CephalonCares Foundation Patient Assistance Programs
• Reimbursement Assistance
• Product Information Request
• Customer Support Services
• Clinical Trials Information

Home > Healthcare Professionals > Our Products > State Compliance

State Compliance

Cephalon is committed to compliance with state requirements for the sale and distribution of our pharmaceutical products. The links below contain information relating to our state compliance efforts.

• Information for Vermont Prescribers of Prescription Drugs - PROVIGIL® and NUVIGIL®
• Information for Vermont Prescribers of Prescription Drugs - AMRIX®
• Information for Vermont Prescribers of Prescription Drugs - FENTORA®
• Information for Vermont Prescribers of Prescription Drugs - GABITRIL®

Cephalon is committed to pedigree/compliance with state requirements for the sale and distribution of our pharmaceutical products.

• Authorized Distributors of Record